MX2017015037A - Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas. - Google Patents

Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas.

Info

Publication number
MX2017015037A
MX2017015037A MX2017015037A MX2017015037A MX2017015037A MX 2017015037 A MX2017015037 A MX 2017015037A MX 2017015037 A MX2017015037 A MX 2017015037A MX 2017015037 A MX2017015037 A MX 2017015037A MX 2017015037 A MX2017015037 A MX 2017015037A
Authority
MX
Mexico
Prior art keywords
inositol
kcal
compositions containing
elevated level
nutritional compositions
Prior art date
Application number
MX2017015037A
Other languages
English (en)
Inventor
Hondmann Dirk
Rudolph Colin
Kuang Chenzhong
Xiao Yan
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of MX2017015037A publication Critical patent/MX2017015037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/64—Sugar alcohols
    • A23V2250/641—Inositol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a un método para mejorar la salud y el desarrollo neurológicos en un sujeto, que involucra la administración al sujeto de una composición nutritiva que incluye no más de aproximadamente 7 g/100 kcal de una fuente de grasa o de lípidos; no más de aproximadamente 7 g/100 kcal de una fuente de proteínas o de un equivalente de proteína; al menos aproximadamente 5 g/100 kcal de un carbohidrato; y al menos aproximadamente 9 mg/100 kcal de inositol, en donde la proporción del inositol exógeno con respecto al inositol inherente es de al menos 50: 50.
MX2017015037A 2015-06-03 2016-05-03 Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas. MX2017015037A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/729,132 US10525016B2 (en) 2015-06-03 2015-06-03 Nutritional compositions containing an elevated level of inositol and uses thereof
PCT/US2016/030500 WO2016195888A1 (en) 2015-06-03 2016-05-03 Nutritional compositions containing an elevated level of inositol and uses thereof

Publications (1)

Publication Number Publication Date
MX2017015037A true MX2017015037A (es) 2018-04-13

Family

ID=55919923

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017015037A MX2017015037A (es) 2015-06-03 2016-05-03 Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas.

Country Status (12)

Country Link
US (2) US10525016B2 (es)
EP (1) EP3302102A1 (es)
CN (1) CN107660124A (es)
AR (1) AR104835A1 (es)
AU (1) AU2016271185A1 (es)
BR (1) BR112017025339A2 (es)
CA (1) CA2987905A1 (es)
HK (1) HK1250132A1 (es)
MX (1) MX2017015037A (es)
PH (1) PH12017502181A1 (es)
TW (1) TW201707582A (es)
WO (1) WO2016195888A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3389407T (pt) 2015-12-14 2024-01-19 Nestle Sa Composição nutricional e fórmula para lactentes para promover mielinização de novo
US20180160714A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) * 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
GB2566971B (en) * 2017-09-28 2020-12-02 Mjn Us Holdings Llc Infant formula having decreased protein content
US11701404B2 (en) * 2017-12-01 2023-07-18 Societe Des Produits Nestle S.A. Human milk fortifier composition
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN108653308B (zh) * 2018-05-07 2021-07-02 黑龙江中医药大学 江户樱花苷在治疗阿尔茨海默中的应用
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
CN112089724A (zh) * 2020-10-10 2020-12-18 新疆医科大学 一种芜菁酸性多糖brap-2的应用
EP4353261A1 (en) * 2021-06-09 2024-04-17 Hospital Sant Joan de Deu Nutraceutic combination and its use in the treatment of neurological disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
WO1992012711A1 (en) 1991-01-24 1992-08-06 Martek Corporation Microbial oil mixtures and uses thereof
SE9101149D0 (sv) 1991-04-17 1991-04-17 Pharmacia Lkb Biotech Beads for down stream processing
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
US5340603A (en) 1993-08-30 1994-08-23 Abbott Laboratories Nutritional product for human infants having chronic lung disease
TW282398B (es) 1993-12-22 1996-08-01 Bristol Myers Squibb Co
EP0744901B1 (en) 1994-02-16 2001-12-05 Pharming Intellectual Property BV Isolation of lactoferrin from milk
SE9503926D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorptionsförfarande och separationsmedium
US6194009B1 (en) 1996-11-22 2001-02-27 Princeton Nutrition, Llc Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
US6039985A (en) 1996-11-22 2000-03-21 Princeton Nutrition, L.L.C. Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
EP1087828B1 (en) 1998-06-18 2008-09-17 Upfront Chromatography A/S Expanded bed adsorption system
AU5823801A (en) 2000-05-12 2001-11-20 Upfront Chromatography As A bed adsorption system
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
EP2272378B1 (en) 2001-06-01 2014-08-06 Upfront Chromatography A/S Fractionation of protein containing mixtures
US20030099722A1 (en) 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
US20030134851A1 (en) 2001-10-09 2003-07-17 Baxter Jeffrey H. Methods and compositions for providing glutamine
AU2003218623B2 (en) 2002-03-07 2008-01-17 Upfront Chromatography A/S A process of isolating lactoferrin
EP1555896A1 (en) 2002-10-08 2005-07-27 Abbott Laboratories Methods and compositions for providing glutamine
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
WO2005068480A1 (en) 2004-01-15 2005-07-28 Biolab Ltd. Sphingomyelin, intermediates thereof and methods for preparation of same
CA2594776A1 (en) 2005-01-14 2006-07-20 Solae, Llc Soy protein for infant formula
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2011069987A1 (en) 2009-12-08 2011-06-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
WO2012170021A1 (en) * 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
US20140179775A1 (en) 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
CN103379358B (zh) * 2012-04-23 2015-03-18 华为技术有限公司 评估多媒体质量的方法和装置
US9345360B2 (en) 2012-05-04 2016-05-24 Brian Sims Method of making infant formula and related devices
US9301966B2 (en) 2013-01-11 2016-04-05 Mead Johnson Nutrition Company Nutritional compositions containing magnesium threonate and uses thereof
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20150119322A1 (en) 2013-07-31 2015-04-30 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof

Also Published As

Publication number Publication date
WO2016195888A1 (en) 2016-12-08
AU2016271185A1 (en) 2017-11-23
CA2987905A1 (en) 2016-12-08
US20200085762A1 (en) 2020-03-19
BR112017025339A2 (pt) 2018-07-31
US10525016B2 (en) 2020-01-07
HK1250132A1 (zh) 2018-11-30
CN107660124A (zh) 2018-02-02
AR104835A1 (es) 2017-08-16
PH12017502181A1 (en) 2018-05-28
US20160354323A1 (en) 2016-12-08
EP3302102A1 (en) 2018-04-11
TW201707582A (zh) 2017-03-01

Similar Documents

Publication Publication Date Title
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2017002626A (es) Composicion que contiene una mezcla de extractos vegetales o una mezcla de moleculas contenidas en dichas plantas y uso para controlar el metabolismo de glucidos y/o lipidos.
SG10201909093XA (en) Mixed allergen compositions and methods for using the same
PH12015501751A1 (en) Nutritional compositions containing an enriched lipid fraction and uses thereof
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2017008815A (es) Composicion que contiene quitina y proteinas digeribles.
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
SG10201806854XA (en) Compositions comprising 15-ohepa and methods of using the same
NZ747847A (en) Lipid compositions
MX2016012694A (es) Composiciones nutritivas dirigidas a sujetos que tienen alergias a proteinas de la leche de vaca.
MX2018011991A (es) Composiciones para el cuidado bucal con una exhibicion de saborizante eficaz.
TW201613632A (en) Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction
NZ753163A (en) Liquid allergen compositions and methods for making the same
EA201592003A1 (ru) Микропищевые добавки для иммунитета
MX2016006817A (es) Composicion liquida fortificante de leche con un contenido de lipidos relativamente alto.
MY177974A (en) A pharmaceutical composition for prevention of diet induced obesity
MX2017006639A (es) Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso.
MX2015012548A (es) Metodos para estimular la maduracion de pulmones e intestinos infantiles.
MX2017006638A (es) Metodos y composiciones para el incremento de la masa corporal magra y minimizar la ganancia de grasa corporal y el control del peso.
MY186341A (en) Nutritional compositions containing an elevated level of inositol and uses thereof
MX2023005014A (es) Metodos de tratamiento de enfermedades inflamatorias cronicas.
TW201613489A (en) Hydrolyzed lactose-containing nutritional compositions and uses thereof